Cost-effectiveness analysis of bivalent respiratory syncytial virus prefusion F (RSVpreF) maternal vaccine for the prevention of RSV illness among infants in Hong Kong
Objectives: Respiratory syncytial virus (RSV) is a leading cause of hospital admissions for acute respiratory infection among infants. A novel RSV prefusion F protein subunit (RSVpreF) vaccine has been recently approved in Hong Kong. The clinical and economic burden of RSV among infants in Hong Kong...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2026-05-01
|
| Серія: | International Journal of Infectious Diseases |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S1201971226001384 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|